VIVUS's (VVUS) Avanafil has won approval -Bloomberg
Tweet
Share
E-mailGet Alerts VVUS Hot Sheet
Join SI Premium – FREE
Bloomberg reporting VIVUS's (Nasdaq: VVUS) Avanafil has won approval
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Getty Realty discloses separation terms for departing accounting officer
- GitLab releases version 19.3 with AI gateway and secrets tools
- Firm Capital Apartment REIT posts Q2 loss, plans name change
Create E-mail Alert Related Categories
Corporate News, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
